Uploaded February 2025 | Updated September 2026, 3 weeks ago
Linked videos:
youtu.be/UEc-AK_A4GU?si=OzXzh_UNZAj7-dCT
youtu.be/ObKrzxHT0n0?si=I2d8t780w9wHW4B8
*MUST WATCH* youtu.be/VxVYHP0WNfA?si=57DzfyuGSP0vJYdS
youtu.be/t2a3DBCJeP0?si=bbgaggqbvSDBMea9
Sources:
1. Imperato-McGinley J. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review. Eur Urol. 1991;20 Suppl 1:78-81. doi:10.1159/000471751
2. Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997;109(3):296-300. doi:10.1111/1523-1747.ep12335779
3. Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554.
4. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor. The Journal of Clinical Endocrinology & Metabolism. 2004;89(5):2179-2184. doi:10.1210/jc.2003-030330
5. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology. 2006;55(6):1014-1023. doi:10.1016/j.jaad.2006.05.007
6. Hobo Y, Nishikawa J, Taniguchi Asai N, et al. Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair. Clinica Chimica Acta. 2023;547:117456. doi:10.1016/j.cca.2023.117456
Linked videos:
youtu.be/UEc-AK_A4GU?si=OzXzh_UNZAj7-dCT
youtu.be/ObKrzxHT0n0?si=I2d8t780w9wHW4B8
*MUST WATCH* youtu.be/VxVYHP0WNfA?si=57DzfyuGSP0vJYdS
youtu.be/t2a3DBCJeP0?si=bbgaggqbvSDBMea9
Sources:
1. Imperato-McGinley J. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review. Eur Urol. 1991;20 Suppl 1:78-81. doi:10.1159/000471751
2. Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997;109(3):296-300. doi:10.1111/1523-1747.ep12335779
3. Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554.
4. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor. The Journal of Clinical Endocrinology & Metabolism. 2004;89(5):2179-2184. doi:10.1210/jc.2003-030330
5. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology. 2006;55(6):1014-1023. doi:10.1016/j.jaad.2006.05.007
6. Hobo Y, Nishikawa J, Taniguchi Asai N, et al. Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair. Clinica Chimica Acta. 2023;547:117456. doi:10.1016/j.cca.2023.117456
